Building knowledge, skills and capacity in pharmacovigilance
We are ambitious to support pharmacovigilance professionals around the world, and to spread the message of safer use of medicines as widely as possible. Our education, training and communications activities cover an extensive field of skills. These pages examine our education and training programme for professionals, while Communication in pharmacovigilance examines important related issues.
UMC's experienced staff and our expert partners from around the world offer a wide range of programmes and resources. Together, we cover a wide range of technical topics and skills related to best practice in pharmacovigilance, as well as essential studies in communications, crisis management and much more. These help new and established staff develop their professional practice in many settings, especially in national pharmacovigilance centres.
There are hands-on and web-based courses, webinars, videos, user-group meetings and publications. The popular annual course is hosted in Uppsala each May.
UMC organises a two-week pharmacovigilance training course in Uppsala, Sweden each year.
Date: 4-15 May 2020
Location: Uppsala, Sweden
UMC participates in the two-week Asia-Pacific course, run by the Pharmacovigilance Programme of India each year, in India.
Date: 24 February - 7 March 2020
Location: Ghaziabad, India
The International Society of Pharmacovigilance and UMC collaborate in providing training in Asia and Latin America.
Date: 11-12 November 2019
Location: Guangzhou, China
UMC has developed a new online course on signal detection and causality assessment. Each lesson is short, concise and connected to a clear learning objective.
Users of WHODrug can access a range of training and webinars, as well as User Group meetings in several regions of the world.
Uppsala University offers two distance-learning courses in pharmacovigilance each semester, in collaboration with UMC.
Search Uppsala University's course selection for information and admission to the courses "Preclinical Safety Assessment and Pharmacovigilance" and "Drug Safety and Pharmacovigilance".